Delivery Order SPE2DB25D2207-SPE2DB25FQQKC

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,788.48, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of QULIPTA 60 MG TABLET 30S. The $2,131.38 firm-fixed-price contract has a completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of medical commodities to support military...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,623.91, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024 and is a firm fixed-price delivery order. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a $4,084.23 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.28 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,609.64 and is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a completion date of January 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a $3,147.63 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of November 24, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QULIPTA 30 MG TABLET 30S. The award, valued at $1,237.79, has an ultimate completion date of September 3, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 and running through December 2025. The IDC enables the DLA to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,301.39, is for the delivery of QULIPTA 30 MG TABLET 30S, a prescription medication. The contract is a firm-fixed price award, without any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, will fulfill this order from its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,688.97 firm fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with a completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB25D2207
    Indefinite Delivery Contract
  • SPE2DB25D2207-SPE2DB25FQQKC
    Delivery Order

This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,148.32 firm-fixed-price contract is for the delivery of QULIPTA 60 MG TABLET 30S, a medication.

The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:44 PM